Skip to content
  • Knowledge Hub
  • Careers
  • News & Events
  • Contact Us
CatSci CatSci
  • Home
  • Who we are
  • What we do
    • Small Molecule
      Early Development
    • Small Molecule
      Late Development
    • Route Scouting and Selection
    • High Potency APIs
    • Solid State & Preformulation
    • Analytical Science
    • Separation Science
    • Oligonucleotides
  • SmartPath
  • Digital Walkthrough
  • Knowledge Hub
  • Careers
  • News & Events
  • Contact Us

Patents

CatSci’s patents are accelerating medicines development with their innovative solutions.

Categories
BlogBook ChaptersCase StudiesPapersPatentsPresentationsThought LeadersWebinarsWhitepapers
Tags
Analytical Chemistry Analytical Science Artificial Intelligence (AI) Biocatalysis Catalysis CatSci Paper CatSci Patent Chemical Development Design of Experiments Digital Drug Development Experimental Design Green Chemistry Industry insights Innovation Machine Learning (ML) Material Science Medium Throughput Experimentation Oligonucleotides Principal Component Analysis Process R&D PROTACs QbD Route Scouting and Selection Scale-up Scavenging Solvents Sustainability Technology transfer Work-up
Process for the preparation of bromodomain inhibitor

WO2020023438

2020 By Antonio M. Ruda, et al.
Process for the preparation of a stereospecific form of flurbiprofen, or a pharmaceutically ...

WO2016110708

2016 By CatSci team, et al.
Process for the removal and return of a catalyst to a liquid phase medium

WO2014083109

2014 By CatSci team, et al.
1H-Pyrazolo[3,4-b]pyridine Derivatives as Protein Kinase Inhibitors and their Preparation an...

WO2011094273

2011 By Guy Brenchley, et al.
Tri-cyclic pyrazolopyridine kinase inhibitors

WO 2010/011772

2010 By Guy Brenchley, et al.
Preparation of [1H-pyrazolo[3,4-b]pyridin-4-yl]phenyl or pyridin-2-yl derivatives as protein...

WO2009073300

2009 By Guy Brenchley, et al.
Thiophene-carboxamides useful as inhibitors of protein kinases

US2009286840

2009 By Guy Brenchley, et al.
Process for preparation of optically active sulfonylethylhydroxylamines by acid hydrolysis o...

WO 2008/029087

2008 By Simon N. G. Tyler, et al.
Preparation of chiral organic hydroxylamines via cyanomethylideneamine oxides

WO 2008/029090

2008 By Simon N. G. Tyler, et al.
Compounds useful as protein kinase inhibitors

WO 2008/060597

2008 By Guy Brenchley, et al.
Preparation of 5-cyano-4-(pyrrolo[2,3-b]pyridin-3-yl)pyrimidines as polo-like kinase (PLK) i...

WO2008079346

2008 By Guy Brenchley, et al.
Process for preparation of benzoic acid derivatives

WO 2007/052001

2007 By Simon N. G. Tyler, et al.

Helpful Links

  • Contact Us
  • Careers
  • Safety, Health and Environment
  • Privacy Policy
  • CatSci Corporate and Social Responsibility (CSR) Policy 2024

What we do

  • Small Molecule Late Development
  • Small Molecule Early Development
  • Route Scouting and Selection
  • Analytical Science
  • High Potency APIs
  • Solid State and Preformulation
  • Oligonucleotides

Who we are

CatSci Ltd are an award-winning innovation partner for medicines development who are committed to creating tailored solutions from candidate selection through product launch and beyond. We break down the silos in small molecules, TACS, glues and oligonucleotides CMC development to accelerate the delivery of life-changing medicines to patients in need. 

© 2024 CatSci Ltd. All rights reserved.
Registered in England & Wales.
Company No. 07466141.